2023 annual financial data
Bionano Genomics 2023 Net margin
Direct answer
Net margin was -643.74%.
Operating income was -215,245,000 USD and net income was -232,493,000 USD.
Operating cash flow was -125,181,000 USD.
Get free Bionano Genomics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 36,116,000 USD
- Operating income
- -215,245,000 USD
- Net income
- -232,493,000 USD
- Operating cash flow
- -125,181,000 USD